Interface Biologics

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Company growth
Type
Private
HQ
Toronto, CA
Founded
2001
Size (employees)
23 (est)
Interface Biologics was founded in 2001 and is headquartered in Toronto, CA

Interface Biologics Office Locations

Interface Biologics has office in Toronto
Toronto, CA

Interface Biologics Metrics

Interface Biologics Summary

Founding Date

2001

Total Funding

$32 M

Time since last funding

about 2 years

Investors

We estimate that Interface Biologics's current employees are approximately 32% female and 68% male.

Interface Biologics Online Presence

Interface Biologics Company Life